Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
29.30
-0.04 (-0.14%)
At close: Jun 23, 2026, 4:00 PM EDT
29.24
-0.06 (-0.19%)
After-hours: Jun 23, 2026, 7:47 PM EDT
Legend Biotech Market Cap
Legend Biotech has a market cap or net worth of $5.44 billion as of June 23, 2026. Its market cap has decreased by -15.63% in one year.
Market Cap
5.44B
Enterprise Value
5.00B
1-Year Change
-15.63%
Ranking
Category
Stock Price
$29.30
Market Cap Chart
Since June 5, 2020, Legend Biotech's market cap has increased from $4.79B to $5.44B, an increase of 13.71%. That is a compound annual growth rate of 2.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 5.44B | 35.54% |
| Dec 31, 2025 | 4.02B | -32.74% |
| Dec 31, 2024 | 5.97B | -45.43% |
| Dec 29, 2023 | 10.94B | 30.89% |
| Dec 30, 2022 | 8.36B | 16.46% |
| Dec 31, 2021 | 7.18B | 92.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Centessa Pharmaceuticals | 6.22B |
| Cogent Biosciences | 6.13B |
| Scholar Rock Holding | 5.89B |
| CG Oncology | 5.84B |
| Belite Bio | 5.79B |
| Xenon Pharmaceuticals | 5.30B |
| Ligand Pharmaceuticals | 5.25B |
| CRISPR Therapeutics AG | 5.24B |